Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 380-381, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diamandis, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diamandis, E. P.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:380-381.)
© 2001 American Association for Clinical Chemistry, Inc.

Editorial

Signal Amplification in Time-resolved Fluorometry

Eleftherios P. Diamandis

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Ave., Toronto, Ontario, M5G 1X5 Canada, and, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada, Fax 416-586-8628, E-mail ediamandis@mtsinai.on.ca

A frequent question among clinical biochemists is how sensitive analytical techniques should be in the context of clinical diagnostics. Currently, the analyte concentrations usually encountered in clinical chemistry range from 10-3 to 10-12 mol/L. By far, the most sensitive nonamplification techniques used in the clinical laboratory are based on noncompetitive immunological assays. Is there any need for measuring analytes at even lower concentrations? The answer is likely yes. Once the methodologies for measuring even lower concentrations of analytes are developed and our knowledge of the many new candidate biological markers that likely will be discovered through the Human Genome Project is more complete, we may be interested in or need to measure analyte concentrations that are 1/10th to 1/100th of those currently measured. Hence, we should continually pursue the development of methodologies that can reach the ultimate sensitivity, i.e., detection of single molecules.

In other areas of laboratory medicine, e.g., microbiology, single pathogen particles (e.g., viruses and bacteria) have diagnostic significance. We should not forget that the measurement of a single molecule in a very small fraction of the total blood volume may mean that the whole organism could contain relatively large numbers of such pathogenic or abnormal constituents. When the analytes are nucleic acids (DNA or RNA), PCR and other exponential amplification . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
Y. Xu and Q. Li
Multiple Fluorescent Labeling of Silica Nanoparticles with Lanthanide Chelates for Highly Sensitive Time-Resolved Immunofluorometric Assays
Clin. Chem., August 1, 2007; 53(8): 1503 - 1510.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.